ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications - Scorecard - MDSpire

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications

  • By

  • Torsten Kucharzik

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Stuart Taylor

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Mariangela Allocca

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Johan Burisch

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Pierre Ellul

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Marietta Iacucci

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Christian Maaser

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Pamela Baldin

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Gauraang Bhatnagar

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Shomron Ben-Horin

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Dominik Bettenworth

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Mallory Chavannes

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Ann Driessen

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Emma Flanagan

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Frederica Furfaro

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Giovanni Maconi

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Konstaninos Karmiris

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Amelia Kellar

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Isabelle De Kock

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Konstantinos Katsanos

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Uri Kopylov

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Cathy Lu

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Olga Maria Nardone

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Nurulamin M Noor

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Kerri Novak

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Paula Borralho Nunes

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Patrick van Rheenen

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Jordi Rimola

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Francesca Rosini

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • David Rubin

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Martina Scharitzer

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Jaap Stoker

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Mathieu Uzzan

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Stephan Vavricka

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Bram Verstockt

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Rune Wilkens

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Nina Zidar

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Alessandra Zilli

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Henit Yanai

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Roger Feakins

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • July 31, 2025

  • 0 min

Share

Clinical Scorecard: Guideline from ECCO-ESGAR-ESP-IBUS on the Diagnosis and Monitoring of Inflammatory Bowel Disease Patients: Part 1 - Initial Assessment, Ongoing Monitoring, and Complication Detection

At a Glance

CategoryDetail
ConditionInflammatory Bowel Disease (IBD)
Key MechanismsChronic inflammation of the gastrointestinal tract requiring diagnostic and monitoring modalities including endoscopy, imaging, and histopathology
Target PopulationPatients with suspected or confirmed inflammatory bowel disease
Care SettingGastroenterology clinics, surgical units, radiology and pathology departments, multidisciplinary IBD management teams

Key Highlights

  • Colonoscopy with terminal ileum intubation and histopathology remains the cornerstone for initial IBD diagnosis.
  • The guideline is a multi-society consensus involving ECCO, ESGAR, ESP, and IBUS, updating 2018 recommendations.
  • Recommendations cover initial diagnosis, complication detection, monitoring tools, and special situations such as pregnancy and postoperative care.

Guideline-Based Recommendations

Diagnosis

  • Perform full colonoscopy including terminal ileum intubation unless contraindicated.
  • Obtain mucosal biopsies for histopathological examination to confirm diagnosis.
  • Use a combination of diagnostic modalities including endoscopy, imaging (intestinal ultrasound, MRE), and pathology for comprehensive assessment.

Management

  • Utilize diagnostic tools to monitor disease activity in both active and inactive phases.
  • Apply specific diagnostic approaches in special clinical scenarios such as pregnancy, postoperative status, and cancer surveillance.

Monitoring & Follow-up

  • Employ imaging modalities such as intestinal ultrasound and magnetic resonance enterography (MRE) for ongoing disease monitoring.
  • Use endoscopic assessment periodically to evaluate mucosal healing and detect complications.

Risks

  • Consider contraindications to colonoscopy and tailor diagnostic approach accordingly.
  • Recognize potential gaps in evidence and apply consensus recommendations with clinical judgment.

Patient & Prescribing Data

Patients diagnosed with or suspected of having inflammatory bowel disease

Diagnostic and monitoring strategies guide therapeutic decisions but specific prescribing data are not detailed in this guideline.

Clinical Best Practices

  • Engage multidisciplinary teams including gastroenterologists, surgeons, radiologists, pathologists, and nurses in IBD management.
  • Incorporate patient representatives in guideline development and clinical decision-making.
  • Follow systematic literature review and consensus methodology to inform diagnostic and monitoring protocols.

References

Original Source(s)

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications

  • by Torsten Kucharzik, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Stuart Taylor, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Mariangela Allocca, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Johan Burisch, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Pierre Ellul, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Marietta Iacucci, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Christian Maaser, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Pamela Baldin, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Gauraang Bhatnagar, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Shomron Ben-Horin, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Dominik Bettenworth, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Mallory Chavannes, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Ann Driessen, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Emma Flanagan, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Frederica Furfaro, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Giovanni Maconi, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Konstaninos Karmiris, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Amelia Kellar, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Isabelle De Kock, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Konstantinos Katsanos, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Uri Kopylov, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Cathy Lu, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Olga Maria Nardone, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Nurulamin M Noor, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Kerri Novak, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Paula Borralho Nunes, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Patrick van Rheenen, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Jordi Rimola, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Francesca Rosini, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), David Rubin, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Martina Scharitzer, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Jaap Stoker, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Mathieu Uzzan, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Stephan Vavricka, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Bram Verstockt, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Rune Wilkens, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Nina Zidar, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Alessandra Zilli, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Henit Yanai, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Roger Feakins, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • July 31, 2025

Related Content

Integrating Double-Balloon Enteroscopy into the Diagnostic Pathway for Suspected Small Bowel Crohn’s Disease: A Retrospective Study from a Tertiary Care Center

Curbing Drug-Related Halitosis for Closer Moments

Individuals who have drug-related halitosis may need to take additional steps to prioritize oral health before intimate encounters.

Urologic malignancy risk with chronic tumor necrosis factor-alpha inhibitor (TNF-I) exposure: a multicenter, retrospective cohort study